VIEWPOINT | Proposed drug patent reforms would do more harm than good
By Andrei Iancu and David Kappos, Council for Innovation Promotion
Congress is considering a bill that could exacerbate government waste and give American companies' most valuable trade secrets to China.
That's obviously not lawmakers' goal. But it's likely to happen — if the Medication Affordability and Patent Integrity Act, introduced by Senators Maggie Hassan (D-NH) and Mike Braun (R-IN), becomes law.
